2021 Maker in China - Hong Kong Chapter

The final of the 2021 “Maker in China” SME Innovation and Entrepreneurship Global Contest – Hong Kong Chapter was held in Cyberport on August 18, 2021. More than 100 teams contestants in this contest, the most ever, and the response was overwhelming. The contestant’s projects have a total of 100 patents, and as many as 70% of the entrants have also won other well-known international innovation and technology competitions. It has facilitated 50 meetings with investors and corporate representatives to conduct financing matching, and introduce innovative ideas from start-ups into the Greater Bay Area. , to promote the overall industrial development of the Greater Bay Area as an international innovation and technology center.
2019 創客中國
國際中小企業創新創業大賽
香港分站賽
2019年由國家工信部中國中小企業發展促進中心、香港特別行政區政府政府資訊科技總監辦公室、中央人民政府駐香港特別行政區聯絡辦公室教育技部共同主辦,賽事吸引逾90個創新創業項目,超過80位博士及大學教授參與,成功吸引6,000萬意向投資,香港代表亦晉身全球10強。

2021

Maker in China

SME Innovation and Entrepreneurship Global Contest
Hong Kong Chapter

2019

創客中國

國際中小企業創新創業大賽 – 香港分站賽

^
June 2021

Two Contest Briefing Sessions

Due to COVID19, the Contest Organising Committee held two online briefing sessions in Cyberport on June 23 and June 29 respectively, inviting experts from different I&T fields to share and introduce the details of the contest and introduce the winning projects in the past.

^
August 2021
Semi-final, top ten projects were selected

The conference held the semi-finals at Tuspark in Hong Kong. Eight industry experts were invited to serve as assessors. The participating projects underwent a roadshow to select the top ten projects that entered the final.

^
August 18, 2021
Hong Kong Chapter Final

Final was held at Cyberport on 18 August.8, The final contest will be held online and will be held simultaneously with the Guangzhou Industrial Park. Five experts from Hong Kong and Guangzhou will be sent to judge the finals.

Opening Addresses by Representatives of the Organisers and Co-organiser

Mr.Zhou Jian

Deputy Director of China Centre for Promotion of SME Development
Ministry of Industry and Information Technology of the People’s Republic of China

Mr. Victor Lam

Government Chief Information Officer
The Government of the Hong Kong Special Administrative Region

Prof. Song Lai

Deputy Director, Department of Youth Affairs,
Liaison Office of the Central People’s Government in the
Hong Kong Special Administrative Region

Mr. Peter Yan

CEO of Hong Kong Cyberport

Hong Kong Chapter Final

Neuropix Company Ltd

Dr. Daniel Ko
Founder & CEO

Magnum Research Limited

Ms. Caroline York
Corporate Communication Manager

MG MedCare Biotechnology Limited

Dr. Helen Huang
Research Director

Dayta AI Limited

Ms. Miranda Huang
Strategy Manager

HONG KONG BAUHINIA TCM LIMITED

Mr. Tian
Founder

Benefit Vantage Limited

Mr. Peter Luk
Chief Information Officer

SyZyGy Limited

Ms. Queenie So
Founder

I2Cool Limited

Mr. Martin Zhu
Co-Founder

Greater Bay Biotechnology Limited

Mr. Colin Ng
Founder

MAD GAZE LIMITED

Ms. Chelsea Miu
Brand Director

Champion

An Energy-free and Low-cost Daytime Passive Radiative Cooling Paint for Energy Saving in Buildings and Decarbonization

I2Cool Limited

Award representatives :
Mr. Zhu, Co-Founder of I2Cool Limited (Right 2)
Mr. Lee, Co-Founder of I2Cool Limited (Right 1)
Mr. Lam, Co-Founder of I2Cool Limited (Left 1)

Presenter :
Mr. Victor Lam
Government Chief Information Officer
The Government of the Hong Kong Special Administrative Region
(Left 2)

1st Runner up

MAD Gaze Smart Glasses

MAD GAZE LIMITED

Award representative :
Ms. Chelsea Miu, Brand Director of MAD Gaze Limited (Right)

Presenter :
Mr. Peter Yan
CEO of Cyberport (Left)

2nd Runner up

Functional Hyaluronic Acid and Innovative Microneedle with wide applications in medicine and cosmetics

Greater Bay Biotechnology Limited

Award representatives :
Mr. Colin Ng, Founder and CEO of Greater Bay Biotechnology Limited (Right)

Presenter :
Mr. Ivan Shum, Chairman of Angel Investment Foundation (Left)

Merit Projects

NEUROPIX
AQUMON
MG MEDCARE
DAYTA AI
IPification
SYZYGY
* The ranking is based on the order of project application date
Top 20 Finalists

抗病毒除甲醛自潔耐久塗層

森寶科技有限公司

ARGUS 視頻 AI

雲影天光科技國際有限公司

Non-invasive Cardiovascular Screening by Hemodynamics

Cardiax Lab Asia Limited

Thermal Thick Film Integrated Circuit TTFIC and QOOLMATE

STANG Ltd

第三代中藥護膚科技的醫療美容場景的應用與商業化

Gihon Biotech Limited

基於骨傳導振動信號 智能手錶虛擬交互鍵盤

振科智慧科技有限公司

"Nanocross" 無菌空間消毒系統

Nanocross Technology Ltd

精密製造工藝設計雲

大藍蛇科技(香港)有限公司

Emotion AI Powered Modern Call Tools and Big Data Platform

MindSense Tehnologies Ltd

中藥產品溯源及驗證平台

斐歷醫藥科技有限公司

* The ranking is based on the order of project application date
MADGAZE

2021 Global Contest – Champion

2021 HK Chapter – 1st Runner Up

MAD GAZE Smart Glasses

MAD Gaze Limited

MAD Gaze is a world’s top-notch augmented reality (AR) smart glasses company founded in 2013 who has captured 14.3% global market share in 2020 and won over 50 awards in the industry.

With a team of experts over 20 years’ experience in AR Hardware and Software R&D, MAD Gaze dedicates in developing high-end software and hardware for customers. Its core technologies include AR algorithm, hand gesture recognition, optical technology and won nearly 50 patents.

The Company’s objective is to accelerate the world’s adoption of AR by offering highly innovative and economical AR/MR smart glasses. 7 years in the market, MAD Gaze has successfully launched 7 AR smart glasses, including monocular and binocular glasses in both standalone and hybrid versions, and a bone-conduction smartwatch which delivered to over 50 countries and become the bestseller in APAC. MAD Gaze has collaborated with 400 giant enterprises such as Nespresso, Cathay Pacific, IBM, Sony, etc; it is devoted to building innovative smart glasses solutions for both enterprises and consumers to promote digital transformation and accelerate AR deployment in medical, security, education, and other industries.

i2Cool

2021 HK Chapter – Champion

2021 Global Contest – 1st Runner up

An Energy-free and Low-cost Daytime Passive Radiative Cooling Paint for Energy Saving in Buildings and Decarbonization
I2Cool Limited
This project aims to promote a novel energy-free and environment-friendly passive radiative cooling paint (patented in Hong Kong) for energy-saving and decarbonization. The self-developed and high-performance paint features the edge in solar reflection and thermal emission, resulting its significant sub-ambient cooling effect, without consuming electricity and ozone-depleting refrigerants. We have demonstrated its high effectiveness and wide applicability in various scenarios.

Most notably, in a site-building use case (supported by the HKSAR), by applying the cooling paint, the roof surface and the indoor air temperature could be reduced by 20-30 ⁰C and 5-6⁰C, respectively, leading to the 8-10% cooling energy saving potential. Empowered by the remarkable R&D outcomes and the vibrant market environment, the related market potential can be exploited in this project and a promising business prospect is anticipated.

We will collaborate with different parties and organizations in building, energy and paint industries to effectively demonstrate and promote our paint product. Continuous product and business upgrade will also be conducted to maintain our technical competence and business sustainability. Our ultimate goal is to achieve remarkable environmental and social impacts, mitigating the energy shortage and climate change, while facilitating overall sustainable development and economic growth in Hong Kong.

FHA
2021 HK Chapter – 2nd Runner up
Functional Hyaluronic Acid and Innovative Microneedle with wide applications in medicine and cosmetics

Greater Bay Biotechnology Limited

Greater Bay Biotechnology focuses on developing innovative technologies in intradermal and transdermal drug delivery, including the frontier technology for cell delivery. With our patented cryomicroneedles (CMNs) platforms, we have developed a new administration route for therapeutic cells.

Cell therapy is booming in regenerative medicine and immuno-oncology and brings hope to patients of life-threatening diseases, however its usage is limited by the storage, transportation and delivery method. Our CMNs could benefit patients of cell therapies as it allows the storage, transportation, and in situ delivery of living cells. In addition to the CMNs platform, we have expertise in other microneedle platforms, providing reliable dissolvable microneedles (dMNs) for drug delivery. The dMN is based on hyaluronic acid, which is beneficial for providing controlled drug release, preservation of bioactivity for biomacromolecules, and precise penetration depths. We have developed dMNs with applications in scar treatment, anti-obesity treatment, anti-aging treatment and can extend to cancer treatment, and cosmetic applications should demand arises. .

We partner with medical institutions, universities, pharmaceutical companies, cosmetic companies, and healthcare professionals to invent, develop and validate our platform technologies in cell therapy, medical and cosmetic applications.

NEUROPIX

2021 HK Chapter – Merit

Neuropix Smart Medical Neurotechnology for Brain Diseases
Neuropix Company Ltd

Neuropix brings disruptive medical technology innovatively connected to digital healthcare solutions for treating major brain diseases, in a new generation of neurotechnology set to change healthcare.

Using clinical neuromodulation, our European CE approved medical devices are wearable, non-surgical applications for treating brain disorders including depression (the world-leading disease burden by 2030, WHO), migraine and epilepsy. Considering these disorders, there are already over 1.6 and 4 million sufferers that can benefit in Hong Kong and Taiwan, respectively.

With novel bioelectrical medicines, our devices connect wirelessly to the patient’s smart device for medical analytics, giving better support and improving medical treatment decisions by physicians. The portable medical device system provides a powerful platform for up-to-date analysis of health data and treatment routines, towards truly improving healthcare.

Supported with >10 years medical research, there is now tremendous potential across Asia. Neuropix (Cyberport based company) with our world experts are leading the way, using the medical treatment in cases in major hospitals in Hong Kong & Taiwan. Neuropix is also set to lead the expansion to new treatment pipelines for aging-diseases, including use for Alzheimer’s and Parkinson’s disease, for the very vulnerable elderly population that will reach 400 million in China alone by 2040.

AQUMON

2021 HK Chapter – Merit

AQUMON
MAGNUM RESEARCH LIMITED

AQUMON is a Hong Kong-based leading digital wealth management platform. Our mission is to leverage technology to make next-generation investment services smarter, simpler, and more affordable to institutional and individual investors.

Through proprietary algorithms and scalable, technical infrastructure, AQUMON’s automated platform empowers anyone to invest and maximise their returns. Since our launch, we have partnered with 100+ financial institutions, including AIA, China Resources Bank, Affiliate of BOCI and CMB Wing Lung Bank etc.

Since 2019, AQUMON has also launched its Asset Management business to facilitate professional investors with customized, quantamental investment solutions. Our renowned investors include Alibaba Entrepreneurs Fund, affiliate of BOC International Holdings Limited, Hong Kong Government-backed Cyberport, Hong Kong University of Science and Technology, Lenovo Capital and Zheng He Capital Management.

The brand is held under Magnum Research Limited and is licensed with Type 1, 4 and 9 under the Securities and Futures Commission (SFC) of Hong Kong.

MG MEDCARE

2021 HK Chapter – Merit

MG MEDCARE Magnesium Wound Dressing
MG MEDCARE LIMITED

With increasing scientific discoveries, there is growing interest about the benefits of magnesium (Mg) in organ function and maintenance of health. Mg is anticipated to be a spotlight of the health-maintaining elements in the next decade.

Deficiency of Mg would earmark be the beginning of health deterioration. In the past decade, we have engaged in numerous studies relating to the effects of Mg in tissue regeneration. Now the Start-up MG MEDCARE is established based on the efforts in the past decade and is devoted to translating the research outcomes into high-tech wound healing dressing with medical grade Mg for promotion of wound healing via Mg’s effects on angiogenesis and neurogenesis in tissue regeneration.

DAYTA AI

2021 HK Chapter – Merit

Dayta AI Limited

Dayta AI is a SaaS company with a vision to establish a SmartRetail ecosystem that entails Computer Vision and Business Intelligence.

Under the rise of e-commerce and even the pandemic, the role of brick-and-mortar stores is clearer than ever before- Extending excellent service and building trust and relationships with customers. Nevertheless, traditional solutions either require high up-front cost or long hardware installation time. Our innovative cloud solution, Cyclops, only requires existing surveillance footage to run. Users can manage stores on a real-time basis and understand deeper insights through customized business intelligence reports, as a result implement data-driven strategies to enhance sales and shopper experience.

Dayta AI is the winner of Moet Hennessy Innovation Challenge, ICT Startup Award (Software and Apps) Certificate of Merits, and HKRMA Smart Retail Tech Awards (Technology Startups) Gold Award. The three passionate co-founders are selected for the Forbes 30 under 30 Asia 2021.

IPification

2021 HK Chapter – Merit

Hong Kong Bauhinia TCM Telemedicine

Hongkong Bauhinia TCM Limited

Based on Hong Kong’s strengths in Chinese medicine, developing Hong Kong’s TCM telemedicine and helping to internationalize TCM products

Medical. Bauhinia TCM core business process: as a third-party platform to enable doctors and patients to connect and communicate without barriers For doctors: as a tool for doctors to provide telemedicine solutions and help doctors with patient management and education

For patients: to help patients more conveniently access medical treatment and purchase medicines online.

Medicines. Cross-border e-commerce services for proprietary Chinese medicines, helping overseas high-quality proprietary Chinese medicines enter the mainland market through China’s pharmaceutical bonded warehouse policy, helping mainland Chinese proprietary medicine manufacturers to apply for overseas registration as well as helping to open sales channels overseas.

IPification

2021 HK Chapter – Merit

Benefit Vantage Limited

IPification is building the backbone of mobile authentication of today and tomorrow. Readily available across numerous countries and regions, IPification is trusted by some of the leading technology, payment, and OTT companies worldwide.

IPification is a highly secure, credential-less, authentication solution for frictionless user experience on mobile and IoT devices.

By verifying the mobile device (e.g. a smartphone), SIM & phone number via IP address, this patented technology developed by IPification is enabling mobile user authentication, phone verification, and fraud prevention solutions including SIM and Device Swap detection.

The low-cost deployment model also enables fast implementation.

IPification has been implemented in 33 mobile operators on four continents; 45+ mobile operators currently in the implementation phase.

Founded in 2018, with HQ in Hong Kong, IPification has offices and representatives operating in the U.S., the U.K., Serbia, Switzerland, Bosnia, Brazil, India, Vietnam and Pakistan.

SYZYGY

2021 HK Chapter – Merit

“Holoportation” real-time showcasing and interactive device
SyZyGy Limited

“Holoportation”is an interactive experience that can be applied on stage or as venue installation in event industry. This is a box shaped device that can show 1:1 holographic image that seems like a real person is standing inside the box. The hardware of the device is a medium and the software can always be further customized to match with different business use cases.

The device is currently used at Cyberport and is expected to be launched in other types of sectors such as retailing and elderly care. Specifically for event industry, this device is seen as the groundwork for larger holographic stage production opportunities.

China International Cooperation Association of SMEs

Final Judging Panel

Ir. Eric Chan
Chief Public Mission Officer, Cyberport

Prof. Billy Chow
Chair Professor, School of Biological Sciences, Faculty of Science, HKU

Mr. Gump Law
Founder, Guangzhou Hongganguo Information Technology Co., Ltd.

Ms. Erica Ma
Managing Partner of Cocoon Ignite Ventures and Co-Founder of Cocoon

Mr. Chen Ruitao
Chairman, Zhongyuan Technology (Guangdong) Co., Ltd.

Mr. Ivan Shum
Chairman, Angel Investment Foundation

Ms. Li Quliu
Vice President, Guangzhou Lifeng Culture Technology Co., Ltd.

Dr. Samson Tam, JP
Partner, Hong Kong Innoangel Fund

Mr. Junhua Wu
Vice President, Iflytek Co., Ltd

Mr. Jack Xu
Chairman, Guangzhou Lanyi Investment Management Co., Ltd.

* According to the English order of the judge’s surname

Semi-Final Assessors

Mr. Kenson Chung
General Manager, CVP Securities

Teddy Liu
Head of Group Audit & Management Services, New World Development

Mr. Ivan Shum
Chairman, Angel Investment Foundation

Ms. Alice So
Head of Entrepreneurship, Cyberport

Mr. Mingles Tsoi
CXO, Particle X

Mr. Tony Tung
General Manager, Gobi Partners

Mr. Sam Wong
General Manager, Tuspark HK

Mr. Damien Wu
Director of Business Transformation and Innovation, Chinachem Group

* According to the English order of the judge’s surname